Ciftci 2012.

Methods	Single‐centre, randomised study
Participants	Patients with lung cancer
Interventions	Intervention: warfarin in addition to standard anticancer treatment. Warfarin was given orally for 6 months starting on day 1 of chemotherapy at a dose of 5 mg/d to achieve a target international normalised ratio of 1.5 to 2.5. Control: standard anticancer treatment
Outcomes	No clear distinction between primary and secondary outcomes. Outcomes reported in the abstract: overall median survival, response rates (complete + partial), bleeding
Notes